Kaiser Permanente Center for Health Research, Portland, Oregon, USA.
Oregon Health and Sciences University/Portland State University School of Public Health, Portland, Oregon, USA.
Cancer Med. 2024 Jul;13(14):e70033. doi: 10.1002/cam4.70033.
Disparities in cervical cancer screening rates among marginalized groups is a driver of inequalities in cervical cancer. Self-sampling for human papillomavirus (HPV) testing is a newly emerging alternative to clinician-performed testing to screen for cervical cancer, and has high potential to reduce screening barriers in under-screened and marginalized groups. We study the acceptability in of HPV self-sampling and informational materials among Black/African American, Hispanic/Spanish speaking, American Indian/Alaska Native and transgender/nonbinary populations.
We conducted qualitative interviews with patients, ages 30-65, who were Black/African American, Hispanic, American Indian, and/or transgender/nonbinary individuals assigned female at birth. Telephone interviews were conducted in English or Spanish. Patients did not complete the test, rather were asked about the attractiveness, comprehensibility, and acceptability of the HPV self-test, instructions, and messaging.
Among 23 completed interviews (5 American Indian/Alaska Native, 7 Hispanic [2 bilingual, 5 Spanish-speaking], 5 Black/African American, and 6 transgender/nonbinary), patients from all groups thought the test was straightforward and convenient, and they would complete the test at home or in clinic. The transgender/nonbinary patients preferred at-home testing. American Indian and transgender/nonbinary patients liked that the test might avoid pain, discomfort, and invasiveness. All patients liked the letter and instructions. All groups had specific suggestions for making the materials more culturally acceptable.
The HPV self-test and the instructions and materials for use were acceptable for a diverse group of patients. Tailored outreach and messaging should be considered to reduce screening disparities among groups that have been historically underserved by the medical system.
边缘化群体的宫颈癌筛查率存在差异,是导致宫颈癌不平等的一个因素。人乳头瘤病毒(HPV)自我采样检测是一种新兴的替代临床医生进行检测的方法,用于筛查宫颈癌,具有降低未充分筛查和边缘化群体筛查障碍的巨大潜力。我们研究了 HPV 自我采样和信息材料在黑/非裔美国人、西班牙裔/讲西班牙语的人、美洲印第安人/阿拉斯加原住民和跨性别/非二元人群中的可接受性。
我们对年龄在 30-65 岁之间的患者进行了定性访谈,这些患者为黑/非裔美国人、西班牙裔、美洲印第安人,并且/或者出生时被指定为女性的跨性别/非二元个体。电话访谈以英语或西班牙语进行。患者没有进行测试,而是被问到 HPV 自我测试、说明和信息的吸引力、可理解性和可接受性。
在 23 次完成的访谈中(5 名美洲印第安人/阿拉斯加原住民、7 名西班牙裔[2 名双语、5 名讲西班牙语]、5 名黑/非裔美国人、6 名跨性别/非二元个体),所有群体的患者都认为测试简单方便,他们会在家中或诊所进行测试。跨性别/非二元个体更喜欢在家中进行测试。美洲印第安人和跨性别/非二元个体喜欢这种测试可能避免疼痛、不适和侵入性。所有患者都喜欢这封信和说明。所有群体都对使材料更具文化可接受性提出了具体建议。
HPV 自我测试以及使用说明和材料对多样化的患者群体是可接受的。应该考虑进行有针对性的外展和宣传,以减少医疗系统长期服务不足的群体中的筛查差异。